Company news

Zelira Therapeutics Ltd. news in 2023

Zelira Therapeutics Ltd.'s news releases, calls and decks from 2023, newest first.

View company

September 2023 Quarterly Activities Report

October 30, 2023

Zelira closes $3.25M funding as part of HOPE SPV fundraise

August 16, 2023

June 2023 Quarterly Activities Report

July 31, 2023

Zeliras diabetic nerve pain drug outperforms Lyrica

May 31, 2023

Trading Halt

May 28, 2023

ZLD secures additional US$3.25M investment in HOPE SPV

May 21, 2023

March 2023 Quarterly Activities Report

April 27, 2023

Zelira raises A$1.77 million from US-based investors

March 14, 2023

Appendix 4D & FY23 Interim Financial Report

February 28, 2023

Zelira Executive Director Appointed

February 20, 2023

ZLD secures US$8.6 million funding for HOPE 1 US FDA trials

February 14, 2023

December 2022 Quarterly Activities Report

January 30, 2023

Zelira receives $1.14 million cash R&D Tax Incentive

January 30, 2023

Decks in 2023